LDL particle size in familial combined hyperlipidemia: Effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins

Journal of Lipid Research

Volumn 43, Issue 4, 2002, Pages 598-603

  Vakkilainena, Juha ^a   Jauhiainenb, Matti ^b   Ylitaloa, Kati ^c   Nuotioc, Ilpo O ^a   Viikaric, Jorma S A ^b   Ehnholmb, Christian ^c   Taskinena, Marja Riitta ^a,b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b BIOMEDICUM HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cholesteryl ester transfer protein; Dense low density lipoprotein; Hepatic lipase; High density lipoprotein; Hypertriglyceridemia; Lipoprotein lipase; Particle size; Phospholipid transfer protein; Small low density lipoprotein; Triglycerides

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; LIPID; LIPID TRANSFER PROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, LDL; FEMALE; GLYCOPROTEINS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPIDS; LIPOPROTEIN LIPASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTICENTER STUDIES; MULTIVARIATE ANALYSIS; PARTICLE SIZE; PHOSPHOLIPID TRANSFER PROTEINS; REGRESSION ANALYSIS; STATISTICS;

EID: 0036198532     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Familial combined hyperlipidemia workshop
2. Familial lipoprotein disorders in patients with premature coronary artery disease
3. Family study of serum lipids and lipoproteins in coronary heart disease
4. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
5. Inherited suspectibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia
6. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients
7. Defects of lipoprotein metabolism in familial combined hyperlipidaemia
8. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23
9. Replication of linkage of familial combined hyperlipidemia to chromosome lq with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus: The NHLBI family heart study
10. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels
11. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
12. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B
13. Low-density lipoprotein subclass patterns and risk of myocardial infarction
14. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction
15. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Québec Cardiovascular Study
16. Low density lipoprotein particle size and risk of early-onset myocardial infarction in women
17. Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men
18. LDL size and risk of coronary heart disease in elderly men and women
19. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size
20. Conformational differences in human apolipoprotein B-100 among subspecies of low density, lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects
21. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans
22. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
23. Lipoprotein heterogeneity and apolipoprotein B metabolism
24. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic phenotype
25. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia
26. Candidate-gene studies of the atherogenic lipoprotein phenotype: A sib-pair linkage analysis of DZ women twins
27. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: Use of a novel tetranucleotide repeat within the CETP promoter
28. Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype
29. The impact of phospholipid transfer protein (PLTP) on HDL metabolism
30. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency
31. Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns Study
32. Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland
33. An immunochemical method for the selecive measurement of two triglyceride lipases in human postheparin plasma
34. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma
35. Human plasma phospholipid transfer protein causes high density lipoprotein conversion
36. Quantification of human plasma phospholipid transfer protein (PLTP): Relationship between PLTP mass and phospholipid transfer activity
37. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes
38. Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Québec Family Study
39. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study
40. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
41. Change in LDL particle size is associated with change in plasma triglyceride concentration
42. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
43. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
44. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families
45. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia
46. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype
47. Relationship of insulin sensitivity and apoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia